Open AccessVitamin D3 Supplementation for 16 Weeks Improves Flow-Mediated Dilation in Overweight African-American Adults
Author(s) -
Ryan A. Harris,
Jennifer Pedersen-White,
De-Huang Guo,
Inger StallmannJorgensen,
Daniel Keeton,
Ying Huang,
Yashesh Shah,
Haidong Zhu,
Yanbin Dong
Publication year - 2011
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2011.12
Subject(s) - medicine , placebo , vitamin d and neurology , parathyroid hormone , vitamin , vitamin d deficiency , endocrinology , overweight , gastroenterology , body mass index , calcium , alternative medicine , pathology
A growing body of evidence has linked vitamin D deficiency to increased risk of cardiovascular disease. Vitamin D deficiency is also more common in African Americans for whom an increased cardiovascular disease risk exists. This study sought to test the hypothesis that 16 weeks of 60,000 IU monthly supplementation of oral vitamin D(3) would improve flow-mediated dilation (FMD) in African Americans, whereas no change would be observed in the placebo group.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom